StockData
Benitec Biopharma Inc. logo

Benitec Biopharma Inc. (BNTC) stock

BNTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/30
$8.15−0.39 (-4.57%)

Close on Nov 17, 2026Market cap $284.29MP/E –Yield –

Benitec Biopharma cash

Cash and short-term investments held at the end of each period.

Benitec Biopharma's cash was $179.97M at Jun 30, 2026. For fiscal 2026 it was $179.97M, up 84.1% from the year before. The highest annual figure on record is $179.97M in fiscal 2026.

Annual cash

PeriodPeriod endValueChange
FY2026Jun 30, 2026$179.97M+84.1%
FY2025Jun 30, 2025$97.74M+91.9%
FY2024Jun 30, 2024$50.93M+1945.3%
FY2023Jun 30, 2023$2.49M-38.9%
FY2022Jun 30, 2022$4.08M-79.4%
FY2021Jun 30, 2021$19.78M+101.5%
FY2020Jun 30, 2020$9.82M-37.5%
FY2019Jun 30, 2019$15.72M+32.3%
FY2018Jun 30, 2018$11.88M–

Quarterly cash

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jun 30, 2026$179.97M+84.1%
Q3 FY2026CQ1 2026Mar 31, 2026$184.76M+78.6%
Q2 FY2026CQ4 2025Dec 31, 2025$188.79M+141.0%
Q1 FY2026CQ3 2025Sep 30, 2025$94.48M+39.1%
Q4 FY2025CQ2 2025Jun 30, 2025$97.74M+91.9%
Q3 FY2025CQ1 2025Mar 31, 2025$103.45M+630.8%
Q2 FY2025CQ4 2024Dec 31, 2024$78.35M+284.3%
Q1 FY2025CQ3 2024Sep 30, 2024$67.91M+162.4%
Q4 FY2024CQ2 2024Jun 30, 2024$50.93M+1945.3%
Q3 FY2024CQ1 2024Mar 31, 2024$14.16M+115.6%
Q2 FY2024CQ4 2023Dec 31, 2023$20.39M+93.2%
Q1 FY2024CQ3 2023Sep 30, 2023$25.88M+56.4%
Q4 FY2023CQ2 2023Jun 30, 2023$2.49M-38.9%
Q3 FY2023CQ1 2023Mar 31, 2023$6.57M-23.9%
Q2 FY2023CQ4 2022Dec 31, 2022$10.55M-14.5%
Q1 FY2023CQ3 2022Sep 30, 2022$16.55M+5.1%
Q4 FY2022CQ2 2022Jun 30, 2022$4.08M-79.4%
Q3 FY2022CQ1 2022Mar 31, 2022$8.63M-28.0%
Q2 FY2022CQ4 2021Dec 31, 2021$12.34M-11.9%
Q1 FY2022CQ3 2021Sep 30, 2021$15.74M+111.3%
Q4 FY2021CQ2 2021Jun 30, 2021$19.78M+101.5%
Q3 FY2021CQ1 2021Mar 31, 2021$11.99M+5.2%
Q2 FY2021CQ4 2020Dec 31, 2020$14.01M+1.6%
Q1 FY2021CQ3 2020Sep 30, 2020$7.45M-55.2%
Q4 FY2020CQ2 2020Jun 30, 2020$9.82M-37.5%
Q3 FY2020CQ1 2020Mar 31, 2020$11.40M-4.0%
Q2 FY2020CQ4 2019Dec 31, 2019$13.79M–
Q1 FY2020CQ3 2019Sep 30, 2019$16.63M–
Q4 FY2019CQ2 2019Jun 30, 2019$15.72M–
Q4 FY2018CQ2 2018Jun 30, 2018$11.88M–

More Benitec Biopharma figures

See a number that looks wrong?